HistoScanning™ to Detect and Characterize Prostate Cancer-a Review of Existing Literature

Purpose of Review The widely acknowledged limitations of the standard prostate cancer (PCa) diagnostic paradigm have provided an impetus to explore novel imaging modalities to diagnose, localize, and risk stratify PCa. As the body of literature focused on HistoScanning (TM) (HS) grows, there is need for a comprehensive review of the clinical efficacy of this technology. Recent Findings Eighteen original, English language articles were found to adequately study the use of HistoScanning (TM) for prostate cancer diagnosis in the clinical setting. The articles were found by conducting a bibliographic search of PubMed in April 2017 in addition to utilizing references. The studies are divided into four groups based on study design. Study methods and quantitative data are summarized for each of the relevant articles. The results are synthesized to evaluate the utility of HistoScanning(TM) for the purpose of diagnosing PCa. Summary Despite the promise of early pilot studies, there is a lack of consistent results across a number of further investigations of HistoScanning (TM) This becomes increasingly evident as study size increases. As various other modern diagnostic modalities continue to develop, the future of HistoScanning (TM), both alone and in conjunction with these technologies, remains unclear.